US Patent Issued to Daegu-Gyeongbuk Medical Innovation Foundation, Immunoforge on July 7 for "3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-apyridin-3-yl)ethinyl)-n-phenylbenzamide derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer" (South Korean Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,945, issued on July 7, was assigned to Daegu-Gyeongbuk Medical Innovation Foundation (Daegu, South Korea) and Immunoforge Co. Ltd. (Seoul, South Korea).

"3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-apyridin-3-yl)ethinyl)-n-phenylbenzamide derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer" was invented by Doohyun Lee (Daegu, South Korea), Seungyeon Lee (Daegu, South Korea), Ye Ri Han (Daegu, South Korea), Chun Young Im (Daegu, South Korea), So Young Kim (Daegu, South Korea), Nam Hui Kim (Daegu, South Korea), Hwan Geun Choi (Seoul, South Korea), Eunhwa Ko (Incheon, South Korea), Heegyum Moon ...